Clinical Trial Update: A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating the efficacy and safety of guselkumab in adults with moderately to severely active Crohn's disease. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Guselkumab (guselkumab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Crohn's Disease | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-05-07